I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 22% ± 3% | |
| transit amplifying cell | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 22% ± 3% | |
| transit amplifying cell | 3 studies | 25% ± 4% |
Insufficient scRNA-seq data for expression of RCCD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1004.43 | 21 / 21 | 100% | 13.17 | 504 / 504 |
| esophagus | 100% | 936.57 | 1445 / 1445 | 100% | 11.80 | 183 / 183 |
| pancreas | 100% | 891.69 | 328 / 328 | 100% | 9.06 | 178 / 178 |
| kidney | 100% | 1005.06 | 89 / 89 | 100% | 8.33 | 900 / 901 |
| uterus | 100% | 1190.06 | 170 / 170 | 100% | 19.27 | 458 / 459 |
| skin | 100% | 1140.66 | 1808 / 1809 | 100% | 13.05 | 470 / 472 |
| intestine | 100% | 1101.16 | 966 / 966 | 99% | 14.00 | 524 / 527 |
| prostate | 100% | 1167.33 | 245 / 245 | 99% | 7.87 | 499 / 502 |
| adrenal gland | 100% | 1467.45 | 258 / 258 | 99% | 9.91 | 228 / 230 |
| ovary | 100% | 1317.97 | 180 / 180 | 99% | 10.21 | 426 / 430 |
| stomach | 100% | 912.19 | 358 / 359 | 99% | 12.02 | 284 / 286 |
| breast | 100% | 686.02 | 459 / 459 | 99% | 9.00 | 1107 / 1118 |
| liver | 100% | 657.60 | 225 / 226 | 99% | 7.66 | 403 / 406 |
| thymus | 100% | 1015.04 | 653 / 653 | 99% | 6.95 | 597 / 605 |
| brain | 98% | 803.69 | 2584 / 2642 | 100% | 10.37 | 705 / 705 |
| lung | 96% | 524.96 | 557 / 578 | 100% | 11.30 | 1155 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 20.26 | 29 / 29 |
| spleen | 100% | 816.33 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.06 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.02 | 1 / 1 |
| adipose | 100% | 629.81 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 806.80 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 9.31 | 79 / 80 |
| heart | 97% | 614.31 | 832 / 861 | 0% | 0 | 0 / 0 |
| muscle | 90% | 329.61 | 724 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 37% | 494.82 | 342 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0005694 | Cellular component | chromosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RCCD1 |
| Protein name | RCC1 domain-containing protein 1 RCC1 domain containing 1 |
| Synonyms | |
| Description | FUNCTION: Plays a role in transcriptional repression of satellite repeats, possibly by regulating H3K36 methylation levels in centromeric regions together with KDM8 . Possibly together with KDM8, is involved in proper mitotic spindle organization and chromosome segregation . Plays a role in regulating alpha-tubulin deacetylation and cytoskeletal microtubule stability, thereby promoting cell migration and TGF-beta-induced epithelial to mesenchymal transition (EMT), potentially through the inhibition of KDM8 . . |
| Accessions | G3V2I3 ENST00000556333.1 ENST00000556618.1 ENST00000555155.5 G3V3Q4 ENST00000394258.7 A6NED2 |
